Literature DB >> 16950745

Inadvertent scleral perforation in eye muscle versus retinal detachment buckle surgery.

Jörn Kuchenbecker1, Klaus Schmitz, Wolfgang Behrens-Baumann.   

Abstract

PURPOSE: Inadvertent scleral perforation is a recognized complication of eye muscle and retinal detachment buckle surgery. If these operations are performed by the same surgeon, it is unknown which of these procedures has a higher risk of scleral perforation.
METHODS: In the period from 1999 until 2004, 427 eyes of 317 patients were operated using eye muscle surgery and 81 eyes of 80 patients with retinal detachment buckle surgery. All operations were performed by the same surgeon (JK). In a retrospective, single-center, comparative, observational study, the records of these patients were assessed to determine the number of scleral perforations with retinal damage or drainage of subretinal fluid.
RESULTS: In the group receiving retinal detachment buckle surgery there were two cases of scleral perforation. In one case, scleral perforation occurred during buckle installation and in the other case during placement of a cerclage. The rate of scleral perforation was 2.5 % per patient and per eye in this group. In the group receiving eye muscle surgery no scleral perforations occurred.
CONCLUSION: The number of scleral perforations was higher in retinal detachment buckle surgery than in eye muscle surgery, with all procedures having been performed by the same surgeon.

Entities:  

Mesh:

Year:  2006        PMID: 16950745     DOI: 10.1080/09273970600896844

Source DB:  PubMed          Journal:  Strabismus        ISSN: 0927-3972


  2 in total

1.  [Comparison of hang-back recession and conventional recession for correction of exotropia].

Authors:  S Schönfeld; S Heede; D J Salchow
Journal:  Ophthalmologe       Date:  2016-05       Impact factor: 1.059

Review 2.  Iatrogenic retinal traumas in ophthalmic surgery.

Authors:  Daniele Tognetto; Maria Teresa di Lauro; Daniela Fanni; Adelia Zagidullina; Luca Michelone; Giuseppe Ravalico
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-07-05       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.